Study title: A prospective, open label, multicenter, international protocol to assess the efficacy and safety of Myfortic® in kidney transplant recipients
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Pathological Conditions, Signs and Symptoms | |||||
Brands: Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: MYCOPHENOLIC ACID | |||||
ATC code: LO4AA06 | |||||
Document link: Myfortic_publication of Article 45 result-related information_final Aug 2011.xls | |||||
Document date: 2011-09-22 | |||||
Study number: ERL080A2405 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |